Brief: Lifecore Biomedical Names Mark Dafonseca Chief Commercial Officer
May 27 (Reuters) - Lifecore Biomedical Inc LFCR.O: LIFECORE BIOMEDICAL NAMES MARK DAFONSECA CHIEF COMMERCIAL OFFICER Source text: ID:nGNX5KbJV0 Further company coverage: LFCR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lifecore Biomedical
See all newsNASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:40 AM
Lifecore Biomedical, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Lifecore Biomedical Reports Financial Results
Lifecore Biomedical Inc expected to post a loss of 22 cents a share - Earnings Preview